Abel S, Vavasour I, Lee LE, Johnson P, Ackermans N, Chan J, Dvorak A, Schabas A, Wiggermann V, Tam R, Kuan AJ, Morrow SA, Wilken J, Laule C, Rauscher A, Bhan V, Sayao AL, Devonshire V, Li DK, Carruthers R, Traboulsee A, Kolind SH (2020a) Myelin damage in normal appearing white matter contributes to impaired cognitive processing speed in multiple sclerosis. J Neuroimaging 30:205–211

Article  PubMed  Google Scholar 

Abel S, Vavasour I, Lee LE, Johnson P, Ristow S, Ackermans N, Chan J, Cross H, Laule C, Dvorak A, Schabas A, Hernández-Torres E, Tam R, Kuan AJ, Morrow SA, Wilken J, Rauscher A, Bhan V, Sayao AL, Devonshire V, Li DKB, Carruthers R, Traboulsee A, Kolind SH (2020b) Associations between findings from myelin water imaging and cognitive performance among individuals with multiple sclerosis. JAMA Netw Open 3:e2014220

Article  PubMed  PubMed Central  Google Scholar 

Akaishi T, Fujimori J, Nakashima I (2024) Basal ganglia atrophy and impaired cognitive processing speed in multiple sclerosis. Cureus 16:e52603

PubMed  PubMed Central  Google Scholar 

Akbarian F, Rossi C, Costers L, D’Hooghe MB, D’Haeseleer M, Nagels G, Van Schependom J (2023) The spectral slope as a marker of excitation/inhibition ratio and cognitive functioning in multiple sclerosis. Hum Brain Mapp 44:5784–5794

Article  PubMed  PubMed Central  Google Scholar 

Al-Iedani O, Lea S, Alshehri A, Maltby VE, Saugbjerg B, Ramadan S, Lea R, Lechner-Scott J (2024) Multi-modal neuroimaging signatures predict cognitive decline in multiple sclerosis: a 5-year longitudinal study. Mult Scler Relat Disord 81:105379

Article  PubMed  Google Scholar 

Alba-Arbalat S, Solana E, Lopez-Soley E, Camos-Carreras A, Martinez-Heras E, Vivó F, Pulido-Valdeolivas I, Andorra M, Sepulveda M, Cabrera JM, Fonseca E, Calvi A, Alcubierre R, Dotti-Boada M, Saiz A, Martinez-Lapiscina EH, Villoslada P, Blanco Y, Sanchez-Dalmau B, Llufriu S (2023) Predictive value of retinal atrophy for cognitive decline across disease duration in multiple sclerosis. J Neurol Neurosurg Psychiatry 95:419–425

Google Scholar 

Alexandra T, Kim C, Estefania B, Elaine R, Pierre D, Isabelle R (2023) Cognitive reserve as a moderating factor between EDSS and cognition in multiple sclerosis. Mult Scler Relat Disord 70:104482

Article  Google Scholar 

Alharthi HM, Almurdi MM (2023) Association between cognitive impairment and motor dysfunction among patients with multiple sclerosis: a cross-sectional study. Eur J Med Res 28:110

Article  PubMed  PubMed Central  Google Scholar 

Altieri M, Cerciello F, Gallo A, Santangelo G (2024) The relationship between depression and cognitive performance in multiple sclerosis: a meta-analysis. Clin Neuropsychol 38:21–41

Article  PubMed  Google Scholar 

Altieri M, Fratino M, Maestrini I, Dionisi C, Annecca R, Vicenzini E, Di Piero V (2020) Cognitive performance in relapsing-remitting multiple sclerosis: at risk or impaired? Dement Geriatr Cogn Disord 49:539–543

Amato MP, Prestipino E, Bellinvia A, Niccolai C, Razzolini L, Pastò L, Fratangelo R, Tudisco L, Fonderico M, Mattiolo PL, Goretti B, Zimatore GB, Losignore NA, Portaccio E, Lolli F (2019) Cognitive impairment in multiple sclerosis: an exploratory analysis of environmental and lifestyle risk factors. PLoS ONE 14:e0222929

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amin M, Ontaneda D (2021) Thalamic injury and cognition in multiple sclerosis. Front Neurol 11:623914

Article  PubMed  PubMed Central  Google Scholar 

Andaloro A, Russo M, Pastura C, Sessa E, Calatozzo P, Maggio MG, Bramanti P (2022) Is there a correlation between dyslipidemia and cognitive impairment in patients with multiple sclerosis? Int J Neurosci 132:201–206

Article  PubMed  Google Scholar 

Argento O, Piacentini C, Bossa M, Caltagirone C, Santamato A, Saraceni V, Nocentini U (2023) Motor, cognitive, and combined rehabilitation approaches on MS patients’ cognitive impairment. Neurol Sci 44:1109–1118

Article  PubMed  Google Scholar 

Artemiadis A, Bakirtzis C, Ifantopoulou P, Zis P, Bargiotas P, Grigoriadis N, Hadjigeorgiou G (2020) The role of cognitive reserve in multiple sclerosis: a cross-sectional study in 526 patients. Mult Scler Relat Disord 41:102047

Article  PubMed  Google Scholar 

Ayromlou H, Hosseini S, Khalili M, Ayromlou S, Khamudchiyan S, Farajdokht F, Hassannezhad S, Amiri Moghadam S (2023) Insulin resistance is associated with cognitive dysfunction in multiple sclerosis patients: a cross-sectional study. J Neuroendocrinol 35:e13288

Article  CAS  PubMed  Google Scholar 

Azzimonti M, Preziosa P, Pagani E, Valsasina P, Tedone N, Vizzino C, Rocca MA, Filippi M (2023) Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study. J Neurol 270:4296–4308

Article  PubMed  Google Scholar 

Baijot J, Van Laethem D, Denissen S, Costers L, Cambron M, D’Haeseleer M, D’Hooghe MB, Vanbinst AM, De Mey J, Nagels G, Van Schependom J (2022) Radial diffusivity reflects general decline rather than specific cognitive deterioration in multiple sclerosis. Sci Rep 12:21771

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bakirtzis C, Ioannidis P, Messinis L, Nasios G, Konstantinopoulou E, Papathanasopoulos P, Grigoriadis N (2018) The rationale for monitoring cognitive function in multiple sclerosis: practical issues for clinicians. Open Neurol J 12:31–40

Article  PubMed  PubMed Central  Google Scholar 

Balloff C, Penner IK, Ma M, Georgiades I, Scala L, Troullinakis N, Graf J, Kremer D, Aktas O, Hartung HP, Meuth SG, Schnitzler A, Groiss SJ, Albrecht P (2022) The degree of cortical plasticity correlates with cognitive performance in patients with multiple sclerosis. Brain Stimul 15:403–413

Article  PubMed  Google Scholar 

Barro C, Healy BC, Saxena S, Glanz BI, Paul A, Polgar-Turcsanyi M, Guttmann CR, Bakshi R, Weiner HL, Chitnis T (2023) Serum NfL but not GFAP predicts cognitive decline in active progressive multiple sclerosis patients. Mult Scler 29:206–211

Article  CAS  PubMed  Google Scholar 

Barros C, Fernandes A (2021) Linking cognitive impairment to neuroinflammation in multiple sclerosis using neuroimaging tools. Mult Scler Relat Disord 47:102622

Article  CAS  PubMed  Google Scholar 

Basci D, Tulek Z (2023) Assessment of cognitive function and its predictors in patients with multiple sclerosis: a case-control study. Neurol Sci 44:1009–1016

Article  PubMed  Google Scholar 

Bellinvia A, Portaccio E, Amato MP (2023) Current advances in the pharmacological prevention and management of cognitive dysfunction in multiple sclerosis. Expert Opin Pharmacother 24:435–451

Article  PubMed  Google Scholar 

Benedict RH, Zivadinov R (2011) Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 7:332–342

Article  PubMed  Google Scholar 

Benedict RH, Weinstock-Guttmam B, Marr K, Valnarov V, Kennedy C, Carl E, Brooks C, Hojnacki D, Zivadinov R (2013) Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis. BMC Med 11:167

Article  PubMed  PubMed Central  Google Scholar 

Benedict RH, Morrow S, Rodgers J, Hojnacki D, Bucello MA, Zivadinov R, Weinstock-Guttman B (2014) Characterizing cognitive function during relapse in multiple sclerosis. Mult Scler 20:1745–1752

Article  PubMed  Google Scholar 

Benedict RHB, Amato MP, DeLuca J, Geurts JJG (2020) Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol 19:860–871

Article  PubMed  PubMed Central  Google Scholar 

Benedict RH, Pol J, Yasin F, Hojnacki D, Kolb C, Eckert S, Tacca B, Drake A, Wojcik C, Morrow SA, Jakimovski D, Fuchs TA, Dwyer MG, Zivadinov R, Weinstock-Guttman B (2021) Recovery of cognitive function after relapse in multiple sclerosis. Mult Scler 27:71–78

Article  CAS  PubMed  Google Scholar 

Bergmann C, Becker S, Watts A, Sullivan C, Wilken J, Golan D, Zarif M, Bumstead B, Buhse M, Kaczmarek O, Covey TJ, Doniger GM, Penner IK, Hancock LM, Bogaardt H, Barrera MA, Morrow S, Gudesblatt M (2023) Multiple sclerosis and quality of life: the role of cognitive impairment on quality of life in people with multiple sclerosis. Mult Scler Relat Disord 79:104966

Article  PubMed  Google Scholar 

Bermel RA, Bakshi R (2006) The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 5:158–170

Article  PubMed  Google Scholar 

Bernabéu-Sanz Á, Morales S, Naranjo V, Sempere ÁP (2021) Contribution of gray matter atrophy and white matter damage to cognitive impairment in mildly disabled relapsing-remitting multiple sclerosis patients. Diagnostics (Basel) 11:578

Article  PubMed  Google Scholar 

Bilgin YOU, Koskderelioglu A, Gedizlioglu M (2023a) Correction to: fall risk is related to cognitive functioning in ambulatory multiple sclerosis patients. Neurol Sci 44:3369

Article  PubMed  Google Scholar 

Bilgin YOU, Koskderelioglu A, Gedizlioglu M (2023b) Fall risk is related to cognitive functioning in ambulatory multiple sclerosis patients. Neurol Sci 44:3233–3242

Article  PubMed  Google Scholar 

Bisecco A, Rocca MA, Pagani E, Mancini L, Enzinger C, Gallo A, Vrenken H, Stromillo ML, Copetti M, Thomas DL, Fazekas F, Tedeschi G, Barkhof F, Stefano ND, Filippi M (2015) Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: a multicenter study. Hum Brain Mapp 36:2809–2825

Article  PubMed  PubMed Central  Google Scholar 

Bisecco A, Capuano R, Caiazzo G, d’Ambrosio A, Docimo R, Cirillo M, Russo A, Altieri M, Bonavita S, Rocca MA, Filippi M, Tedeschi G, Gallo A (2021) Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis. Mult Scler 27:134–138

Article  CAS  PubMed  Google Scholar 

Bizzo BC, Arruda-Sanchez T, Tobyne SM, Bireley JD, Lev MH, Gasparetto EL, Klawiter EC (2021) Anterior insular resting-state functional connectivity is related to cognitive reserve in multiple sclerosis. J Neuroimaging 31:98–102

Article  PubMed